● Single award · contract
Objective of This Task Order Supports Niaids Goal to Conduct a Series of Standardized Phase 1 and Phase 2…
A single federal award, with both ends of the trail linked.
$173.3M
total award value
2023
action date
59 mo
period
75N91023F00008
PIID
Description
The Objective of This Task Order Supports Niaids Goal to Conduct a Series of Standardized Phase 1 and Phase 2 Trials on Next-Generation Vaccines to Generate Data to Inform Decisions on Which Candidates to Support for Advanced Development.
Awarding agencyDepartment of Health and Human Services →
RecipientLeidos Biomedical Research Inc →
Place of performanceMaryland →
CategoryNAICS 541715PSC AN12
Competed?Not recorded✓ from source
Total (exact)$173,281,267
More awards to Leidos Biomedical Research Inc
awarded 2008$4.8B
awarded 2020$1.8B
awarded 2019$432.4M
awarded 2024$398.9M
awarded 2025$327.1M
More from Department of Health and Human Services
awarded 2024$100.1B
awarded 2023$92B
awarded 2022$80.5B
awarded 2021$80.5B
awarded 2022$71.7B
🔎
Why the labels? The graph is only worth anything if the links are trusted. Facts taken straight from a federal filing are ✓ from source; anything we compute or infer (corporate parents, districts, competitors) is ≈ inferred and worded carefully, never asserted as fact.